Capuano R, Altieri M, Conte M, Bisecco A, et al. Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod. J Neurol 2022 Jul 26. pii: 10.1007/s00415-022-11296.
PMID: 35879563